Selected arylpiperazines are capable of reversing multidrug resistance in Escherichia coli overexpressing RND efflux pumps

Antimicrobial Agents and Chemotherapy

Volumn 49, Issue 2, 2005, Pages 849-852

  Bohnert, Jürgen A ^a   Kern, Winfried V ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

1 (1 NAPHTHYL) PIPERAZINE; 1 (1 NAPHTHYLMETHYL) PIPERAZINE; 1 (2 PHENYLETHYL) PIPERAZINE; 1 (2 TRIFLUOROMETHYLPHENYL) PIPERAZINE; 1 (3 CHLOROPHENYL) PIPERAZINE; 1 (3 PHENYLPROPYL) PIPERAZINE; 1 (3 TRIFLUOROMETHYLPHENYL) PIPERAZINE; 1 (4 CHLOROBENZYL) PIPERAZINE; 1 (4 PHENYLBUTYL) PIPERAZINE; 1 (4 TRIFLUOROMETHYLPHENYL) PIPERAZINE; 1 [3 (TRIFLUOROMETHYL)BENZYL] PIPERAZINE; 1 [4 (1 NAPHTHYL)BUTANOYL] PIPERAZINE; 1 [4 (1 NAPHTHYL)BUTYL] PIPERAZINE; 1 [4 (2 NAPHTHYL)BUTYL] PIPERAZINE; 1 [4 (2 NAPHTHYL)BUTYNOL] PIPERAZINE; 1 BENZYLPIPERAZINE DERIVATIVE; 1 ETHYL 4 (1 NAPHTHYL) PIPERAZINE; 1 PHENYL 4 (1 NAPHTHYL) PIPERAZINE; 1 PHENYLPIPERAZINE DERIVATIVE; CHLORAMPHENICOL; CLARITHROMYCIN; ETHIDIUM BROMIDE; LEVOFLOXACIN; LINEZOLID; OXACILLIN; QUIPAZINE; RIFAMPICIN; TETRACYCLINE; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ARTICLE; DRUG ACCUMULATION; DRUG SCREENING; DRUG SENSITIVITY; DRUG SENSITIZATION; DRUG STRUCTURE; ESCHERICHIA COLI; GENE OVEREXPRESSION; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; CARRIER PROTEINS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ESCHERICHIA COLI; MICROBIAL SENSITIVITY TESTS; MUTATION; OFLOXACIN; PIPERAZINES; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 12944316448     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.49.2.849-852.2005     Document Type: Article

References (9)

1. Jellen-Ritter, A. S., and W. V. Kern. 2001. Enhanced expression of the multidrug efflux pumps AcrAB and AcrEF associated with insertion element transposition in Escherichia coli mutants selected with a fluoroquinolone. Antimicrob. Agents Chemother. 45:1467-1472.
2. Kern, W. V., M. Oethinger, A. S. Jellen-Ritter, and S. B. Levy. 2000. Nontarget gene mutations in the development of fluoroquinolone resistance in Escherichia coli. Antimicrob. Agents Chemother. 44:814-820.
3. Li, X. Z., and H. Nikaido. 2004. Efflux-mediated drug resistance in bacteria. Drugs 54:159-204.
4. Lomovskaya, O., M. S. Warren, A. Lee, J. Galazzo, R. Fronko, M. Lee, J. Blais, D. Cho, S. Chamberland, T. Renau, R. Leger, S. Hecker, W. Watkins, K. Hoshino, H. Ishida, and V. J. Lee. 2001. Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa: novel agents for combination therapy. Antimicrob. Agents Chemother. 45:105-116.
5. Mallea, M., A. Mahamoud, J. Chevalier, S. Alibert-Franco, P. Brouant, J. Barbe, and J. M. Pages. 2003. Alkylaminoquinolines inhibit the bacterial antibiotic efflux pump in multidrug-resistant clinical isolates. Biochem. J. 376:801-805.
6. Poole, K. 2004. Efflux-mediated multiresistance in Gram-negative bacteria. Clin. Microbiol. Infect. 10:12-26.
7. Renau, T. E., R. Leger, E. M. Flamme, J. Sangalang, M. W. She, R. Yen, C. L. Cannon, D. Griffith, S. Chamberland, O. Lomovskaya, S. J. Hecker, V. J. Lee, T. Ohta, and K. Nakayama. 1999. Inhibitors of efflux pumps in Pseudomonas aeruginosa potentiate the activity of the fluoroquinolone antibacterial levofloxacin. J. Med. Chem. 42:4928-4931.
8. Sulavik, M. C., C. Houseweart, C. Cramer, N. Jiwani, N. Murgolo, J. Greene, B. DiDomenico, K. J. Shaw, G. H. Miller, R. Hare, and G. Shimer. 2001. Antibiotic susceptibility profiles of Escherichia coli strains lacking multidrug efflux pump genes. Antimicrob. Agents Chemother. 45:1126-1136.
9. Thorarensen, A., A. L. Presley-Bodnar, K. R. Marotti, T. P. Boyle, C. L. Heckaman, M. J. Bohanon, P. K. Tomich, G. E. Zurenko, M. T. Sweeney, and B. H. Yagi. 2001. 3-Arylpiperidines as potentiators of existing antibacterial agents. Bioorg. Med. Chem. Lett. 11:1903-1906.